Leading the way to safer medication
 Crosscheck  Recommender

Ambenonium

Description

Ambenonium (as ambenonium dichloride) is a cholinesterase inhibitor used in the management of myasthenia gravis. Ambenonium exerts its actions against myasthenia gravis by competitive reversible inhibition of acetylcholinesterase, the enzyme responsible for the hydrolysis of acetylcholine.

ATC Classification

Code
Title
Category
N07AA30
Ambenonium
N Nervous system → N07 Other nervous system drugs → N07A Parasympathomimetics → N07AA Anticholinesterases

Trade names

Trade name
Countries

France